Barclays »

Seaport Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Seaport Therapeutics shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Seaport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seaport Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seaport Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $18k 837 21.72

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Seaport Therapeutics

Arch Venture Corp
General Atlantic
Sofinnova Ventures
Goldman Sachs Group
Trv Gp Vi
Canada Pension Plan Investment Board
Jpmorgan Chase & Co
Foresite Capital Management VI
FMR
Bellevue Group
Siren
Jennison Associates
RA Capital Management
Vanguard Capital Management
Woodline Partners

View all funds holding Seaport Therapeutics